Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 5, 1997, Pages 562-568

  Jilma, Bernd ^a   Voltmann, Jann ^b   Albinni, Said ^b   Stohlawetz, Petra ^b   Schwarzinger, Ilse ^b   Gleiter, Christoph H ^b   Rauch, Alexandra ^b   Eichler, Hans Georg ^b   Wagner, Oswald F ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; L SELECTIN;

ADULT; APPETITE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; FLOW CYTOMETRY; HEADACHE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCYTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DEXAMETHASONE; DOUBLE-BLIND METHOD; DOWN-REGULATION; GLUCOCORTICOIDS; HUMANS; L-SELECTIN; LYMPHOCYTES; MALE; NEUTROPHILS; REFERENCE VALUES;

EID: 0031430396     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90052-7     Document Type: Article

References (25)

1. Nelson DH, Ruhmann Wennhold A. Inhibition of leukocyte superoxide anion production by cortisol administration to normal subjects. J Clin Endocrinol Metab 1978;46:702-5.
2. Panarelli M, Holloway CD, Mulatero P, Fraser R, Kenyon CJ. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: an index of glucocorticoid sensitivity. J Clin Endocrinol Metab 1994;78:872-7.
3. Mishler JM, Emerson PM. Development of neutrophilia by serially increasing doses of dexamethasone. Br J Haematol 1977;36:249-57.
4. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304-15.
5. Youssef PP, Cormack J, Evill CA, Peter DT, Roberts Thomson PJ, Ahern MJ, et al. Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Arthritis Rheum 1996;39:216-25.
6. Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-Selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol 1996;167:79-85.
7. Tedder TF, Steeber DA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995; 9:866-73.
8. Burton JL, Kehrli ME Jr, Kapil S, Horst RL. Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol 1995;57:317-25.
9. Burton JL, Kehrli ME Jr. Effects of dexamethasone on bovine circulating T lymphocyte populations. J Leukoc Biol 1996;59:90-9.
10. Czerwinski AW, Czerwinski AB, Whitsett TL, Clark ML. Effects of a single, large, intravenous injection of dexamethasone. Clin Pharmacol Ther 1972;13:638-42.
11. Harris RZ, Tsunoda SM, Mroczkowski P, Wong H, Benet LZ. The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics. Clin Pharmacol Ther 1996; 59:429-35.
12. Legler UF, Benet LZ. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives. Clin Pharmacol Ther 1986;39: 425-9.
13. Slayter KL, Ludwig EA, Lew KH, Middleton E, Jr., Ferry JJ, Jusko WJ. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1996;59:312-21.
14. Hill MR, Szefler SJ, Ball BD, Bartoszek M, Brenner AM. Monitoring glucocorticoid therapy: a pharmacokinetic approach. Clin Pharmacol Ther 1990;48:390-8.
15. Stuck AE, Frey BM, Frey FJ. Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin Pharmacol Ther 1988;43:354-62.
16. Milsap RL, Plaisance KI, Jusko WJ. Prednisolone disposition in obese men. Clin Pharmacol Ther 1984; 36:824-31.
17. Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr, Ferry JJ, et al. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993;54:402-14.
18. Jilma B, Eichler HG, Breiteneder H, Wolzt M, Aringer M, Graninger W, et al. Effects of 17 beta-estradiol on circulating adhesion molecules. J Clin Endocrinol Metab 1994;79:1619-24.
19. O'Leary EC, Marder P, Zuckerman SH. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. Am J Respir Cell Mol Biol 1996;15:97-106.
20. Youssef P, Roberts Thomson P, Ahern M, Smith M. Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype. J Rheumatol 1995;22:2065-71.
21. Kirkpatrick CH. Immunosuppressives. Clin Pharmacol Ther 1974;16:982-5.
22. Duggan DE, Yeh KC, Matalia N, Ditzler CA, McMahon FG. Bioavailability of oral dexamethasone. Clin Pharmacol Ther 1975;18:205-9.
23. Hare LE, Yeh KC, Ditzler CA, McMahon FG, Duggan DE. Bioavailability of dexamethasone; II: dexamethasone phosphate. Clin Pharmacol Ther 1975;18: 330-7.
24. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992; 119: 229-38.
25. Zetterberg E, Richter J. Correlation between serum level of soluble L-selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation. Eur J Haematol 1993; 51:113-9.